nodes	percent_of_prediction	percent_of_DWPC	metapath
Vardenafil—PDE5A—clitoris—polycystic ovary syndrome	0.153	0.495	CbGeAlD
Vardenafil—Angina unstable—Metformin—polycystic ovary syndrome	0.0273	0.119	CcSEcCtD
Vardenafil—Sinus headache—Metformin—polycystic ovary syndrome	0.0212	0.0924	CcSEcCtD
Vardenafil—PDE11A—adrenal gland—polycystic ovary syndrome	0.0145	0.0469	CbGeAlD
Vardenafil—PDE6G—adrenal gland—polycystic ovary syndrome	0.0139	0.0451	CbGeAlD
Vardenafil—Sinus congestion—Metformin—polycystic ovary syndrome	0.0139	0.0605	CcSEcCtD
Vardenafil—PDE11A—endocrine gland—polycystic ovary syndrome	0.0125	0.0407	CbGeAlD
Vardenafil—PDE6H—endocrine gland—polycystic ovary syndrome	0.0125	0.0407	CbGeAlD
Vardenafil—PDE10A—adipose tissue—polycystic ovary syndrome	0.0105	0.034	CbGeAlD
Vardenafil—PDE1B—adipose tissue—polycystic ovary syndrome	0.0104	0.0337	CbGeAlD
Vardenafil—PDE10A—adrenal gland—polycystic ovary syndrome	0.0094	0.0305	CbGeAlD
Vardenafil—PDE1B—adrenal gland—polycystic ovary syndrome	0.00931	0.0302	CbGeAlD
Vardenafil—CYP3A4—urine—polycystic ovary syndrome	0.00896	0.0291	CbGeAlD
Vardenafil—PDE10A—female gonad—polycystic ovary syndrome	0.00876	0.0284	CbGeAlD
Vardenafil—PDE1B—endocrine gland—polycystic ovary syndrome	0.00808	0.0262	CbGeAlD
Vardenafil—Accidental injury—Metformin—polycystic ovary syndrome	0.0078	0.034	CcSEcCtD
Vardenafil—PDE5A—adipose tissue—polycystic ovary syndrome	0.00613	0.0199	CbGeAlD
Vardenafil—Nasal congestion—Metformin—polycystic ovary syndrome	0.0055	0.024	CcSEcCtD
Vardenafil—PDE5A—adrenal gland—polycystic ovary syndrome	0.0055	0.0178	CbGeAlD
Vardenafil—Injury—Metformin—polycystic ovary syndrome	0.00545	0.0238	CcSEcCtD
Vardenafil—PDE5A—female gonad—polycystic ovary syndrome	0.00513	0.0166	CbGeAlD
Vardenafil—PDE5A—vagina—polycystic ovary syndrome	0.0051	0.0165	CbGeAlD
Vardenafil—PDE5A—endocrine gland—polycystic ovary syndrome	0.00477	0.0155	CbGeAlD
Vardenafil—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00463	0.0202	CcSEcCtD
Vardenafil—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00458	0.02	CcSEcCtD
Vardenafil—Breast disorder—Metformin—polycystic ovary syndrome	0.00453	0.0198	CcSEcCtD
Vardenafil—Cramp muscle—Metformin—polycystic ovary syndrome	0.00451	0.0197	CcSEcCtD
Vardenafil—Influenza—Metformin—polycystic ovary syndrome	0.00433	0.0189	CcSEcCtD
Vardenafil—Angina pectoris—Metformin—polycystic ovary syndrome	0.00422	0.0184	CcSEcCtD
Vardenafil—Sildenafil—CYP1A1—polycystic ovary syndrome	0.0039	1	CrCbGaD
Vardenafil—Infestation NOS—Metformin—polycystic ovary syndrome	0.00386	0.0168	CcSEcCtD
Vardenafil—Infestation—Metformin—polycystic ovary syndrome	0.00386	0.0168	CcSEcCtD
Vardenafil—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00365	0.0159	CcSEcCtD
Vardenafil—Rhinitis—Metformin—polycystic ovary syndrome	0.00348	0.0152	CcSEcCtD
Vardenafil—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00345	0.015	CcSEcCtD
Vardenafil—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00341	0.0149	CcSEcCtD
Vardenafil—Eye disorder—Metformin—polycystic ovary syndrome	0.00324	0.0141	CcSEcCtD
Vardenafil—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00322	0.014	CcSEcCtD
Vardenafil—Flushing—Metformin—polycystic ovary syndrome	0.00322	0.014	CcSEcCtD
Vardenafil—Angiopathy—Metformin—polycystic ovary syndrome	0.00315	0.0137	CcSEcCtD
Vardenafil—Immune system disorder—Metformin—polycystic ovary syndrome	0.00313	0.0137	CcSEcCtD
Vardenafil—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00312	0.0136	CcSEcCtD
Vardenafil—Erythema—Metformin—polycystic ovary syndrome	0.00302	0.0132	CcSEcCtD
Vardenafil—Muscle spasms—Metformin—polycystic ovary syndrome	0.0029	0.0127	CcSEcCtD
Vardenafil—Vision blurred—Metformin—polycystic ovary syndrome	0.00284	0.0124	CcSEcCtD
Vardenafil—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.0028	0.0122	CcSEcCtD
Vardenafil—Malaise—Metformin—polycystic ovary syndrome	0.00272	0.0119	CcSEcCtD
Vardenafil—Syncope—Metformin—polycystic ovary syndrome	0.00271	0.0118	CcSEcCtD
Vardenafil—Palpitations—Metformin—polycystic ovary syndrome	0.00267	0.0116	CcSEcCtD
Vardenafil—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00265	0.0116	CcSEcCtD
Vardenafil—Chest pain—Metformin—polycystic ovary syndrome	0.00257	0.0112	CcSEcCtD
Vardenafil—Myalgia—Metformin—polycystic ovary syndrome	0.00257	0.0112	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00255	0.0111	CcSEcCtD
Vardenafil—CYP3A5—adipose tissue—polycystic ovary syndrome	0.00255	0.00826	CbGeAlD
Vardenafil—Discomfort—Metformin—polycystic ovary syndrome	0.00254	0.0111	CcSEcCtD
Vardenafil—Infection—Metformin—polycystic ovary syndrome	0.00245	0.0107	CcSEcCtD
Vardenafil—Shock—Metformin—polycystic ovary syndrome	0.00242	0.0106	CcSEcCtD
Vardenafil—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00242	0.0105	CcSEcCtD
Vardenafil—Skin disorder—Metformin—polycystic ovary syndrome	0.00239	0.0104	CcSEcCtD
Vardenafil—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00238	0.0104	CcSEcCtD
Vardenafil—Hypotension—Metformin—polycystic ovary syndrome	0.0023	0.01	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00224	0.00979	CcSEcCtD
Vardenafil—Paraesthesia—Metformin—polycystic ovary syndrome	0.00221	0.00965	CcSEcCtD
Vardenafil—Dyspnoea—Metformin—polycystic ovary syndrome	0.0022	0.00958	CcSEcCtD
Vardenafil—Somnolence—Metformin—polycystic ovary syndrome	0.00219	0.00955	CcSEcCtD
Vardenafil—Dyspepsia—Metformin—polycystic ovary syndrome	0.00217	0.00946	CcSEcCtD
Vardenafil—CYP3A5—female gonad—polycystic ovary syndrome	0.00213	0.00691	CbGeAlD
Vardenafil—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00213	0.00928	CcSEcCtD
Vardenafil—CYP3A5—vagina—polycystic ovary syndrome	0.00212	0.00687	CbGeAlD
Vardenafil—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00203	0.00885	CcSEcCtD
Vardenafil—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00201	0.00879	CcSEcCtD
Vardenafil—CYP3A5—endocrine gland—polycystic ovary syndrome	0.00198	0.00643	CbGeAlD
Vardenafil—Abdominal pain—Metformin—polycystic ovary syndrome	0.00195	0.00849	CcSEcCtD
Vardenafil—Asthenia—Metformin—polycystic ovary syndrome	0.00177	0.00771	CcSEcCtD
Vardenafil—Pruritus—Metformin—polycystic ovary syndrome	0.00174	0.0076	CcSEcCtD
Vardenafil—Diarrhoea—Metformin—polycystic ovary syndrome	0.00169	0.00735	CcSEcCtD
Vardenafil—Dizziness—Metformin—polycystic ovary syndrome	0.00163	0.0071	CcSEcCtD
Vardenafil—Vomiting—Metformin—polycystic ovary syndrome	0.00157	0.00683	CcSEcCtD
Vardenafil—Rash—Metformin—polycystic ovary syndrome	0.00155	0.00677	CcSEcCtD
Vardenafil—Dermatitis—Metformin—polycystic ovary syndrome	0.00155	0.00677	CcSEcCtD
Vardenafil—Headache—Metformin—polycystic ovary syndrome	0.00154	0.00673	CcSEcCtD
Vardenafil—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00149	0.00482	CbGeAlD
Vardenafil—Nausea—Metformin—polycystic ovary syndrome	0.00146	0.00638	CcSEcCtD
Vardenafil—PDE1B—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000191	0.000417	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—NRG1—polycystic ovary syndrome	0.000191	0.000416	CbGpPWpGaD
Vardenafil—CYP3A5—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.00019	0.000415	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.00019	0.000415	CbGpPWpGaD
Vardenafil—PDE1B—Disease—FGF18—polycystic ovary syndrome	0.00019	0.000414	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—VEGFA—polycystic ovary syndrome	0.000189	0.000412	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—VEGFA—polycystic ovary syndrome	0.000189	0.000412	CbGpPWpGaD
Vardenafil—PDE1B—Disease—RBP4—polycystic ovary syndrome	0.000188	0.000411	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000188	0.000411	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000188	0.00041	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—GAB1—polycystic ovary syndrome	0.000188	0.00041	CbGpPWpGaD
Vardenafil—PDE6G—Disease—MTHFR—polycystic ovary syndrome	0.000187	0.000407	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000186	0.000407	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000186	0.000406	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000184	0.0004	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000183	0.0004	CbGpPWpGaD
Vardenafil—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000183	0.000399	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000183	0.000398	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000178	0.000389	CbGpPWpGaD
Vardenafil—PDE6G—Disease—IRS2—polycystic ovary syndrome	0.000178	0.000388	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—PRL—polycystic ovary syndrome	0.000177	0.000385	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signaling of activated FGFR—IL6—polycystic ovary syndrome	0.000176	0.000384	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000174	0.00038	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000174	0.000379	CbGpPWpGaD
Vardenafil—PDE1B—Disease—GAB1—polycystic ovary syndrome	0.000174	0.000378	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000173	0.000376	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—PRL—polycystic ovary syndrome	0.000172	0.000375	CbGpPWpGaD
Vardenafil—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000171	0.000373	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CAMK2D—polycystic ovary syndrome	0.000171	0.000372	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—GNAS—polycystic ovary syndrome	0.00017	0.000371	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—NMNAT3—polycystic ovary syndrome	0.00017	0.00037	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000169	0.000369	CbGpPWpGaD
Vardenafil—PDE1B—Disease—NAMPT—polycystic ovary syndrome	0.000169	0.000369	CbGpPWpGaD
Vardenafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000169	0.000368	CbGpPWpGaD
Vardenafil—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000169	0.000367	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—TNRC6B—polycystic ovary syndrome	0.000168	0.000367	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000168	0.000365	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000166	0.000362	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signal transduction—IL6—polycystic ovary syndrome	0.000166	0.000361	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR—IL6—polycystic ovary syndrome	0.000165	0.000359	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by ERBB2—IL6—polycystic ovary syndrome	0.000164	0.000358	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000164	0.000357	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000163	0.000356	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—IRS2—polycystic ovary syndrome	0.000163	0.000356	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—CRP—polycystic ovary syndrome	0.000163	0.000356	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 signaling—IL6—polycystic ovary syndrome	0.000163	0.000356	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000162	0.000353	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000159	0.000347	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000159	0.000346	CbGpPWpGaD
Vardenafil—PDE1B—Disease—AKR1C3—polycystic ovary syndrome	0.000158	0.000344	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000155	0.000339	CbGpPWpGaD
Vardenafil—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000155	0.000339	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—LPCAT2—polycystic ovary syndrome	0.000155	0.000339	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—SUOX—polycystic ovary syndrome	0.000155	0.000339	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—FST—polycystic ovary syndrome	0.000155	0.000338	CbGpPWpGaD
Vardenafil—PDE1B—Disease—TNRC6B—polycystic ovary syndrome	0.000155	0.000338	CbGpPWpGaD
Vardenafil—PDE6G—Disease—IRS1—polycystic ovary syndrome	0.000155	0.000338	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000154	0.000336	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR in disease—IL6—polycystic ovary syndrome	0.000154	0.000335	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 interactions—IL6—polycystic ovary syndrome	0.000154	0.000335	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000153	0.000334	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR—IL6—polycystic ovary syndrome	0.000152	0.000332	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—LHB—polycystic ovary syndrome	0.000152	0.00033	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000151	0.00033	CbGpPWpGaD
Vardenafil—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000151	0.00033	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR in Cancer—IL6—polycystic ovary syndrome	0.000151	0.000329	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—IL6—polycystic ovary syndrome	0.00015	0.000327	CbGpPWpGaD
Vardenafil—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000149	0.000325	CbGpPWpGaD
Vardenafil—PDE6G—Disease—INS—polycystic ovary syndrome	0.000149	0.000324	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000148	0.000323	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000148	0.000323	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—ATF1—polycystic ovary syndrome	0.000148	0.000322	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—IGF1—polycystic ovary syndrome	0.000147	0.00032	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—AKT2—polycystic ovary syndrome	0.000147	0.00032	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000145	0.000317	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ISYNA1—polycystic ovary syndrome	0.000144	0.000315	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000144	0.000315	CbGpPWpGaD
Vardenafil—CYP3A5—Biological oxidations—POMC—polycystic ovary syndrome	0.000144	0.000314	CbGpPWpGaD
Vardenafil—PDE6G—Disease—AKT2—polycystic ovary syndrome	0.000144	0.000313	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000143	0.000313	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000143	0.000312	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—IRS1—polycystic ovary syndrome	0.000143	0.000311	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—SCT—polycystic ovary syndrome	0.000142	0.00031	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000142	0.000309	CbGpPWpGaD
Vardenafil—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000141	0.000307	CbGpPWpGaD
Vardenafil—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000141	0.000307	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.00014	0.000306	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—SERPINE1—polycystic ovary syndrome	0.000139	0.000304	CbGpPWpGaD
Vardenafil—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000139	0.000303	CbGpPWpGaD
Vardenafil—PDE6G—Disease—SERPINE1—polycystic ovary syndrome	0.000137	0.000298	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—TAB1—polycystic ovary syndrome	0.000136	0.000297	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000136	0.000297	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—IL6—polycystic ovary syndrome	0.000136	0.000296	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000135	0.000295	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—PRL—polycystic ovary syndrome	0.000135	0.000294	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—LEP—polycystic ovary syndrome	0.000133	0.00029	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000133	0.00029	CbGpPWpGaD
Vardenafil—PDE1B—Disease—TCF7L2—polycystic ovary syndrome	0.000133	0.00029	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000132	0.000288	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—AKT2—polycystic ovary syndrome	0.000132	0.000288	CbGpPWpGaD
Vardenafil—PDE1B—Disease—SLC2A4—polycystic ovary syndrome	0.000131	0.000285	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.00013	0.000283	CbGpPWpGaD
Vardenafil—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000126	0.000275	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PRL—polycystic ovary syndrome	0.000125	0.000272	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000125	0.000271	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000123	0.000269	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—AKR1C2—polycystic ovary syndrome	0.000123	0.000268	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—TEAD2—polycystic ovary syndrome	0.000123	0.000268	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—LEP—polycystic ovary syndrome	0.000122	0.000266	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000122	0.000265	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000121	0.000265	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000119	0.000259	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—LEP—polycystic ovary syndrome	0.000119	0.000259	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—INSR—polycystic ovary syndrome	0.000116	0.000253	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—BCL2—polycystic ovary syndrome	0.000115	0.000251	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—POMC—polycystic ovary syndrome	0.000114	0.000249	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—INS—polycystic ovary syndrome	0.000114	0.000248	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL18—polycystic ovary syndrome	0.000114	0.000248	CbGpPWpGaD
Vardenafil—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000111	0.000243	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—NRG1—polycystic ovary syndrome	0.000111	0.000242	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.00011	0.000241	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—IGF1—polycystic ovary syndrome	0.00011	0.00024	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—AKT2—polycystic ovary syndrome	0.00011	0.00024	CbGpPWpGaD
Vardenafil—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.00011	0.000239	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000109	0.000237	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000109	0.000237	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PGR—polycystic ovary syndrome	0.000108	0.000235	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000106	0.000231	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—POMC—polycystic ovary syndrome	0.000105	0.000228	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—IL6—polycystic ovary syndrome	0.000105	0.000228	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000105	0.000228	CbGpPWpGaD
Vardenafil—PDE1B—Disease—NCOR1—polycystic ovary syndrome	0.000104	0.000228	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—INS—polycystic ovary syndrome	0.000104	0.000227	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PNPLA2—polycystic ovary syndrome	0.000103	0.000224	CbGpPWpGaD
Vardenafil—PDE1B—Disease—NRG1—polycystic ovary syndrome	0.000103	0.000224	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—POMC—polycystic ovary syndrome	0.000102	0.000222	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—INS—polycystic ovary syndrome	0.000101	0.000221	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000101	0.000219	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000101	0.000219	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PLAT—polycystic ovary syndrome	0.0001	0.000218	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—GHRL—polycystic ovary syndrome	0.0001	0.000218	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—IGF1—polycystic ovary syndrome	9.81e-05	0.000214	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—AKT2—polycystic ovary syndrome	9.8e-05	0.000214	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—SRD5A1—polycystic ovary syndrome	9.75e-05	0.000213	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—POMC—polycystic ovary syndrome	9.64e-05	0.00021	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—VEGFA—polycystic ovary syndrome	9.58e-05	0.000209	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.56e-05	0.000208	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—ATF1—polycystic ovary syndrome	9.54e-05	0.000208	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CRP—polycystic ovary syndrome	9.51e-05	0.000207	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IRS2—polycystic ovary syndrome	9.51e-05	0.000207	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.32e-05	0.000203	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	9.31e-05	0.000203	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—STAR—polycystic ovary syndrome	9.31e-05	0.000203	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	9.26e-05	0.000202	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MTHFR—polycystic ovary syndrome	9.23e-05	0.000201	CbGpPWpGaD
Vardenafil—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	8.98e-05	0.000196	CbGpPWpGaD
Vardenafil—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	8.85e-05	0.000193	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NGFR—polycystic ovary syndrome	8.81e-05	0.000192	CbGpPWpGaD
Vardenafil—PDE1B—Disease—IRS2—polycystic ovary syndrome	8.78e-05	0.000191	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—POMC—polycystic ovary syndrome	8.75e-05	0.000191	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PRL—polycystic ovary syndrome	8.73e-05	0.00019	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—IL6—polycystic ovary syndrome	8.42e-05	0.000184	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—AKT2—polycystic ovary syndrome	8.41e-05	0.000183	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IRS1—polycystic ovary syndrome	8.3e-05	0.000181	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—HMMR—polycystic ovary syndrome	8.29e-05	0.000181	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—ADRB2—polycystic ovary syndrome	8.28e-05	0.000181	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—HSD3B1—polycystic ovary syndrome	7.91e-05	0.000172	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	7.9e-05	0.000172	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—AKT2—polycystic ovary syndrome	7.69e-05	0.000168	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—GNAS—polycystic ovary syndrome	7.68e-05	0.000167	CbGpPWpGaD
Vardenafil—PDE1B—Disease—IRS1—polycystic ovary syndrome	7.67e-05	0.000167	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—IL6—polycystic ovary syndrome	7.5e-05	0.000164	CbGpPWpGaD
Vardenafil—PDE1B—Disease—INS—polycystic ovary syndrome	7.34e-05	0.00016	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NCOR1—polycystic ovary syndrome	7.31e-05	0.000159	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	7.22e-05	0.000157	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	7.22e-05	0.000157	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—LHB—polycystic ovary syndrome	7.22e-05	0.000157	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—VEGFA—polycystic ovary syndrome	7.19e-05	0.000157	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NRG1—polycystic ovary syndrome	7.18e-05	0.000157	CbGpPWpGaD
Vardenafil—PDE1B—Disease—AKT2—polycystic ovary syndrome	7.1e-05	0.000155	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—HSD3B2—polycystic ovary syndrome	7.05e-05	0.000154	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—AKR1C1—polycystic ovary syndrome	6.83e-05	0.000149	CbGpPWpGaD
Vardenafil—PDE1B—Disease—SERPINE1—polycystic ovary syndrome	6.74e-05	0.000147	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	6.71e-05	0.000146	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—BCL2—polycystic ovary syndrome	6.71e-05	0.000146	CbGpPWpGaD
Vardenafil—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	6.69e-05	0.000146	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.58e-05	0.000143	CbGpPWpGaD
Vardenafil—PDE6G—Disease—IL6—polycystic ovary syndrome	6.5e-05	0.000142	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.41e-05	0.00014	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—SULT2A1—polycystic ovary syndrome	6.29e-05	0.000137	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IRS2—polycystic ovary syndrome	6.15e-05	0.000134	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—RRM2—polycystic ovary syndrome	6.09e-05	0.000133	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—LEP—polycystic ovary syndrome	6.02e-05	0.000131	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—IL6—polycystic ovary syndrome	5.97e-05	0.00013	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—YAP1—polycystic ovary syndrome	5.87e-05	0.000128	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	5.71e-05	0.000124	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	5.71e-05	0.000124	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—NAMPT—polycystic ovary syndrome	5.64e-05	0.000123	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CYP11A1—polycystic ovary syndrome	5.57e-05	0.000121	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IRS1—polycystic ovary syndrome	5.37e-05	0.000117	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—AKR1C3—polycystic ovary syndrome	5.26e-05	0.000115	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CYP17A1—polycystic ovary syndrome	5.18e-05	0.000113	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—POMC—polycystic ovary syndrome	5.17e-05	0.000113	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—INS—polycystic ovary syndrome	5.14e-05	0.000112	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—IL6—polycystic ovary syndrome	4.97e-05	0.000108	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IGF1—polycystic ovary syndrome	4.97e-05	0.000108	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—AKT2—polycystic ovary syndrome	4.97e-05	0.000108	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	4.78e-05	0.000104	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.72e-05	0.000103	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—IL6—polycystic ovary syndrome	4.55e-05	9.92e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	4.53e-05	9.89e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—TH—polycystic ovary syndrome	4.48e-05	9.76e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—IL6—polycystic ovary syndrome	4.43e-05	9.66e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—SLC2A4—polycystic ovary syndrome	4.36e-05	9.5e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	4.33e-05	9.43e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CYP19A1—polycystic ovary syndrome	4.1e-05	8.93e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	3.86e-05	8.41e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—IL6—polycystic ovary syndrome	3.8e-05	8.29e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	3.68e-05	8.02e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	3.66e-05	7.97e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	3.48e-05	7.59e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL6—polycystic ovary syndrome	3.47e-05	7.57e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	3.35e-05	7.31e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	3.3e-05	7.2e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	3.28e-05	7.15e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.25e-05	7.08e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—IL6—polycystic ovary syndrome	3.21e-05	6.99e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	3.18e-05	6.92e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	3.08e-05	6.71e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	2.92e-05	6.37e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	2.83e-05	6.17e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	2.73e-05	5.95e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	2.62e-05	5.71e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	2.59e-05	5.64e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	2.5e-05	5.44e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	2.46e-05	5.37e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—INS—polycystic ovary syndrome	2.45e-05	5.34e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	2.44e-05	5.33e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	2.41e-05	5.25e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IL6—polycystic ovary syndrome	2.25e-05	4.9e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—TH—polycystic ovary syndrome	2.08e-05	4.54e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	2.03e-05	4.42e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	1.9e-05	4.15e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	1.7e-05	3.71e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	1.62e-05	3.53e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	1.54e-05	3.35e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	1.43e-05	3.12e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.16e-05	2.53e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.14e-05	2.5e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.14e-05	2.48e-05	CbGpPWpGaD
